DOI:
10.1055/s-00000104
Zentralblatt für Chirurgie
LinksClose Window
References
Vincent JL, Bernard GR, Beale R. et al
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment.
Crit Care Med 2005; 33: 2266-2277
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.